Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
9 /100
LOW RISK
Score updated Aug 28, 2026

VRTX — Vertex Pharmaceuticals Incorporated Dilution Risk Tracker

Track VRTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VRTX — Get alerts when the score changes →

As of August 28, 2026, Vertex Pharmaceuticals Incorporated (VRTX) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. Vertex Pharmaceuticals Incorporated has a market capitalization of $113.59B, 253.46M shares outstanding, 1698 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for VRTX.
🔔 Track VRTX — Get forecast alerts →

Market Data

Market Cap$113.59B
Shares Outstanding253.46M
Float253.02M
Cash$7.85B
Debt$105.00M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 20.0% shares (2026Q1 vs prior)
1698 institutional holders · 294.36M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 33.03M shares
#2 Capital World Investors 25.37M shares
#3 BlackRock, Inc. 23.97M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.94M
Days to Cover3.0
% of Float1.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2013-12-31
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-03-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual VRTX Dilution Snapshot

Vertex Pharmaceuticals Incorporated (VRTX) has a DilutionScore of 9/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track VRTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VRTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VRTX
VRTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.